Insight Molecular Diagnostics Inc.IMDXEarnings & Financial Report
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
IMDX Q4 FY2025 Key Financial Metrics
Revenue
$1.1M
Gross Profit
$484.0K
Operating Profit
$-23.4M
Net Profit
$-23.0M
Gross Margin
42.5%
Operating Margin
-2057.5%
Net Margin
-2015.4%
YoY Growth
-23.4%
EPS
$-0.75
Insight Molecular Diagnostics Inc. Q4 FY2025 Financial Summary
Insight Molecular Diagnostics Inc. reported revenue of $1.1M (down 23.4% YoY) for Q4 FY2025, with a net profit of $-23.0M (up 31.5% YoY) (-2015.4% margin). Cost of goods sold was $655.0K, operating expenses totaled $23.9M.
Key Financial Metrics
| Total Revenue | $1.1M |
|---|---|
| Net Profit | $-23.0M |
| Gross Margin | 42.5% |
| Operating Margin | -2057.5% |
| Report Period | Q4 FY2025 |
Insight Molecular Diagnostics Inc. Annual Revenue by Year
Insight Molecular Diagnostics Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $4.1M).
Insight Molecular Diagnostics Inc. Quarterly Revenue & Net Profit History
Insight Molecular Diagnostics Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $1.1M | -23.4% | $-23.0M | -2015.4% |
| Q3 FY2025 | $260.0K | +126.1% | $-10.9M | -4174.6% |
| Q2 FY2025 | $518.0K | +398.1% | $-9.7M | -1880.7% |
| Q1 FY2025 | $2.1M | +1114.8% | $-6.7M | -312.0% |
| Q4 FY2024 | $1.5M | +373.2% | $-33.5M | -2255.1% |
| Q3 FY2024 | $115.0K | -73.2% | $-13.5M | -11733.0% |
| Q2 FY2024 | $104.0K | -77.5% | $-4.5M | -4355.8% |
| Q1 FY2024 | $176.0K | -40.7% | $-9.1M | -5186.9% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $176000 | $104000 | $115000 | $1.5M | $2.1M | $518000 | $260000 | $1.1M |
| YoY Growth | -40.7% | -77.5% | -73.2% | 373.2% | 1114.8% | 398.1% | 126.1% | -23.4% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $71.0M | $74.7M | $70.2M | $35.1M | $60.4M | $50.5M | $43.9M | $25.8M |
| Liabilities | $54.1M | $52.0M | $60.5M | $47.4M | $50.1M | $49.4M | $53.1M | $57.2M |
| Equity | $11.6M | $22.7M | $9.7M | $-12.3M | $10.2M | $1.1M | $-9.2M | $-31.5M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-3.8M | $-6.0M | $-5.5M | $-5.4M | $-5.9M | $-6.3M | $-4.5M | $-5.5M |